Fondazione Santa Lucia

Fondazione Santa Lucia (FSL) is the first Italian Institute for Research in the neuroscience field for hospitalisation and treatment. The institute has approximately 60 laboratories and the Laboratory of Neuropsychiatry is leader in development of operational research diagnostic criteria for diagnosis of Alzheimer's disease and cognitive impairment, preventive rehabilitation activities in the following phases: preclinical, clinical, CSF biomarkers and specific patterns of brain tissue damage/dysfunction detected by quantified multiparametric imaging techniques enable to preventive diagnose and recognize the atypical forms of disease at an early stage. The Laboratory of Neuropsychiatry is currently involved in three AAL projects (2016 PETAL, 2018 POSITIVE and 2019 ReMember-Me).